FDA Issues Alert On Drugs' Link To Muscle Injury

Word Count: 312 | Companies Featured in This Article: Merck, Schering-Plough, Abbott Laboratories, Wyeth, Pfizer WASHINGTON -- Federal regulators continue to receive reports of muscle injury in patients taking a combination of simvastatin, which is used in the controversial cholesterol drug Vytorin, and the heart-rhythm medication amiodarone. Patients taking amiodarone and doses of simvastatin higher than 20 milligrams a day are at particular risk for suffering from a rare muscle injury that can lead to kidney... [read full story]